Newsroom | 12634 results

NEW YORK--(BUSINESS WIRE)--RYALTRIS® nasal spray for seasonal allergic rhinitis is now available through BlinkRx. Transfer your Rx or visit blinkrx.com to learn more....

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the publication of its 2025 Sustainability Report, showcasing progress across its operations, products, people, and community. The report underscores how Insulet’s sustainability strategy continues to strengthen its mission of transforming life for people with diabetes while preserving the health of...

PARIS--(BUSINESS WIRE)--Clinisys, a global provider of intelligent laboratory informatics solutions, today announced that Clinisys France has officially obtained the Qualiopi certification for its training activities. This nationally recognized certification confirms that Clinisys’s training organization complies with the Référentiel National Qualité (RNQ), the French State quality framework for training providers, and is therefore eligible to deliver training that may be financed through publi...

NEWBURYPORT, Mass.--(BUSINESS WIRE)--UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $17.5 million for its first quarter ended March 31, 2026, 1.8% higher than net income of $17.2 million for the first quarter of 2025. Net sales for the quarter ended March 31, 2026 were $154.2 million, 4.1% higher than 2025 first quarter sales of $148.1 million. GAAP and a...

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC., a leading provider of aesthetic and dermatological solutions, announces today the appointments of Chris House as Chief Technology Officer and Charles Hunt as Vice President of Design and Experience. These strategic appointments underscore Cutera’s commitment to next-generation solutions and customer-centered product development. As Chief Technology Officer, Chris House will lead Cutera’s global technology and product development strategy, focusin...

LOS ANGELES--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of its clinician-directed telehealth platform under Niagen™ Plus, enabling eligible patients in the U.S. to access prescription-only, pharmaceutical-grade Niagen® (patented nicotinamide riboside chloride, NRCl) from home with the first-of-its-kind Niagen® At-Home Injection Kit. The launch m...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced business updates and financial results for the first quarter ended March 31, 2026. Recent Business Highlights Endocardial Catheter AF Ablation Announced strategic prioritization of the nPulse Cardiac Catheter System following landmark clinical data, presented at AF Symposium, demonst...

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that the Company will present at the following conferences in May: Bank of America Healthcare Conference at the Encore Hotel in Las Vegas on May 13, at 2:20 p.m. Pacific time (5:20 p.m. Eastern time) Stifel Jaws & Paws Conference at Lotte Hotel, New York City, on May 27, at 3:00 p.m. Eastern time Henry Schein’s presentati...

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) plans to release financial results for the first quarter of 2026 on Monday, May 11, 2026, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917....

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. Norman Schwartz, Bio-Rad’s Chairman and Chief Executive Officer, stated: "Our first-quarter results reflected our resolve in navigating a dynamic environment. Despite external headwinds including challenging academic end markets and conflict escalation in the...